Evelyn Partners Asset Management LTD Vertex Pharmaceuticals Inc Transaction History
Evelyn Partners Asset Management LTD
- $443 Billion
- Q3 2025
A detailed history of Evelyn Partners Asset Management LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Evelyn Partners Asset Management LTD holds 47 shares of VRTX stock, worth $20,398. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47
Previous 9
422.22%
Holding current value
$20,398
Previous $4.01 Million
359.37%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,791Shares Held
231MCall Options Held
1.84MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA25.9MShares$11.2 Billion1.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.2MShares$10.5 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.25 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.6MShares$7.18 Billion1.27% of portfolio
-
State Street Corp Boston, MA11.6MShares$5.04 Billion0.16% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $111B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...